Cresp Onco 200mcg Injection
By Cresp Onco
Rx
1 Injection in a Vial

Composition
Darbepoetin alfa(200mcg)

Manufacturer - Dr Reddy's Laboratories Ltd
Dr. Reddy's Laboratories Ltd., 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500034, INDIA

Expires on or after
May, 2026

liver
When using Cresp Onco 200mcg Injection, it is important to be cautious if you have liver disease. Patients with liver issues may require adjustments to the dosage of Cresp Onco 200mcg Injection. It is advised to consult your doctor before starting or continuing treatment with this medication.

kidney
Cresp Onco 200mcg Injection is safe for patients with kidney disease. No dose adjustment is needed for this medicine.

alcohol
Consult your doctor when consuming alcohol with Cresp Onco 200mcg Injection.

driving
Cresp Onco 200mcg Injection typically does not impact your driving abilities. No specific safety advice regarding driving is available.

pregnancy
Cresp Onco 200mcg Injection may not be safe to use during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing it to you. It is important to consult your doctor regarding its use during pregnancy.

breastfeeding
Cresp Onco 200mcg Injection may not be safe to use while breastfeeding. Limited data shows it can pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | Amino Acids, Peptides, and Analogues |
Therapeutic Class | BLOOD RELATED |
Action Class | Erythropoiesis-stimulating agent (ESA) |
₹12789.5
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024